ADENTRA Inc.
TSX:ADEN.TOIndustrial - Distribution
+$0.87 today
- Market cap
- $913.81M
- Beta
- 1.36
- P/E (TTM)
- 8.9
- EPS (TTM)
- $2.75
- Dividend yield
- 1.78%
Volume 0.11M
Average 0.06M
ADEN.TO EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
ADENTRA Inc.TSX: ADEN.TO
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) dips below year-ago levels
Q1 FY2026 EPS (Diluted) of $0.08 fell 50.0% year over year, behind the +61.4% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 93.9% from the prior quarter. Over 3 fiscal years it compounded at -29.9% a year.
Context
- EPS (Diluted) increased in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 5 analysts of $2.43 (-11.8%) for the fiscal year ending Dec 2026, a slowdown from the +43.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $0.08-93.9% QoQ
- Last fiscal yearDec 2025
- $2.76+43.7% YoY
- LTMMar 2026
- $2.68+61.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -50.0% | -21.4% | +28.6 pp |
| 1 year | +43.7% | -11.8% | -55.6 pp |
| 3-year CAGR | -29.9% | +7.4% | +37.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
Mixed currencies · from the income statement
- Latest · FY2025
- 2.76 USD
- Year-over-year change
- +43.7%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.76 | +43.7% |
| FY2024 | 2024-12-31 | 1.92 | — |
| FY2023 | 2023-12-31 | 2.11 | -73.7% |
| FY2022 | 2022-12-31 | 8.01 | +33.7% |
| FY2021 | 2021-12-31 | 5.99 | — |
EPS (Diluted) vs competitors
How ADEN.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
- Its year-over-year change of +61.4% is the 2nd highest of 9, against a peer median of +35.7%.
- Over three fiscal years its annual growth of -29.9% compares with a peer median of +13.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | CA$4.15 CAD | +96.0% | +21.5% | |
| LTM Mar 2026 | CA$2.79 CAD | +50.2% | -7.5% | |
| LTM Mar 2026 | $2.68 USD | +61.4% | -29.9% | |
| LTM Jun 2026 | CA$1.09 CAD | +5.8% | -14.6% | |
| LTM Jun 2026 | CA$1.05 CAD | +58.2% | — | |
| LTM Mar 2026 | CA$0.72 CAD | +44.0% | +130.3% | |
| LTM Mar 2026 | CA$0.48 CAD | -1.1% | +7.1% | |
| LTM Mar 2026 | CA$0.21 CAD | +27.4% | +20.5% | |
| LTM Mar 2026 | -CA$3.06 CAD | -40.4% | — | |
| Peer median (excluding ADEN.TO) | — | +35.7% | +13.8% | |
Competitors are the stored peer set for ADEN.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 · CAD | FY2022 Dec 2022 · CAD | FY2023 Dec 2023 · CAD | FY2024 Dec 2024 · USD | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Revenue | 2.06B | 3.47B | 2.97B | 2.18B | 2.29B |
| Cost of Revenue | 1.58B | 2.72B | 2.35B | 1.71B | 1.87B |
| Gross Profit | 475.27M | 748.07M | 617.81M | 474.06M | 419.14M |
| Gross Margin | 23.1% | 21.6% | 20.8% | 21.7% | 18.3% |
| Research & Development | 253.02K | 824.11K | 0 | 0 | 0 |
| Selling, General & Admin | 286.22M | 483.87M | 466.16M | 308.86M | 314.35M |
| Operating Expenses | 286.22M | 483.87M | 495.47M | 377.16M | 314.35M |
| Depreciation & Amortization | 45.86M | 114.5M | 92.59M | 76.1M | 86.51M |
| EBITDA | 231.08M | 461.33M | 214.54M | 169.82M | 191.3M |
| EBITDA Margin | 11.2% | 13.3% | 7.2% | 7.8% | 8.4% |
| Operating Income | 189.05M | 264.2M | 122.35M | 96.91M | 104.79M |
| Operating Margin | 9.2% | 7.6% | 4.1% | 4.4% | 4.6% |
| Interest Income | 688.22K | 1.08M | 828.43K | (4.06M) | 3.31M |
| Interest Expense | 13.46M | 47.71M | 65.09M | 38.43M | 48.85M |
| Other Income / Expenses | (13.61M) | (45.5M) | (65.49M) | (41.61M) | (37.59M) |
| Income Before Tax | 175.43M | 218.7M | 56.86M | 55.29M | 67.2M |
| Pre-Tax Margin | 8.5% | 6.3% | 1.9% | 2.5% | 2.9% |
| Income Tax Expense | 43.98M | 45.82M | 9.08M | 8.82M | (2.43M) |
| Net Income | 131.46M | 172.88M | 47.78M | 46.48M | 69.63M |
| Net Margin | 6.4% | 5.0% | 1.6% | 2.1% | 3.0% |
| EPS (Basic) | 4.81 | 8.06 | 2.13 | 1.95 | 2.83 |
| EPS (Diluted) | 5.99 | 8.01 | 2.11 | 1.92 | 2.76 |
| Weighted Avg Shares | 21.44M | 21.6M | 22.39M | 23.87M | 24.65M |
| Weighted Avg Shares (Diluted) | 21.6M | 21.6M | 22.62M | 24.15M | 25.23M |
ADENTRA Inc.
TSX:ADEN.TO
Intrinsic Alpha fair value
Locked
Current Price
$37.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.